Business Context and Reporting Period
Company: KKR Real Estate Finance Trust Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2022
Reporting Period: Quarter ended June 30, 2022
This filing serves as a notification that the Company issued an earnings release and supplemental financial information for the second quarter of 2022. The detailed financial data is contained in Exhibits 99.1 and 99.2, which are incorporated by reference but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the referenced exhibits (Exhibit 99.1 and Exhibit 99.2) and are not explicitly stated in the body of this 8-K filing.
Material Changes
No specific material changes regarding financial performance or operations are detailed in the text of this filing. The document solely announces the release of the Q2 2022 results.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes standard disclaimers regarding forward-looking statements, noting they are based on current beliefs and assumptions and are subject to risks and uncertainties. The Company does not undertake an obligation to update these statements except as required by law.
Risk Reference: Investors are directed to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021, for detailed information on factors affecting the Company and risks associated with forward-looking statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Release) for specific Q2 2022 revenue, net income, and FFO figures.
- Review Exhibit 99.2 (Supplemental Financial Information) for detailed portfolio metrics, leverage ratios, and liquidity positions.
- Verify the Company's current status regarding the 6.50% Series A Cumulative Redeemable Preferred Stock (KREF PRA) trading on the NYSE.
- Consult the most recent Form 10-K for updated risk factors not explicitly detailed in this 8-K.